Vita Coco Company, Inc.·4

Mar 18, 5:01 PM ET

Burth Jonathan 4

4 · Vita Coco Company, Inc. · Filed Mar 18, 2026

Research Summary

AI-generated summary of this filing

Updated

Vita Coco COO Jonathan Burth Exercises Options & Sells Shares

What Happened

  • Jonathan Burth, Chief Operating Officer of Vita Coco (COCO), exercised stock options to acquire 40,000 shares at an exercise price of $10.18 per share (total cash paid ≈ $407,120) and sold a total of 60,000 shares in open-market transactions on March 16, 2026.
  • The open-market sales included: 20,000 shares at $57.98 ($1,159,600), 8,825 shares at $57.98 ($511,674), 11,175 shares at $57.98 ($647,927), and 20,000 shares at $60.00 ($1,200,000). Gross proceeds from the sales totaled $3,519,201, implying net proceeds of roughly $3.11M after the option exercise cost.
  • The sales were reported as effected pursuant to a Rule 10b5-1 trading plan (see footnote F1), indicating pre‑planned dispositions rather than ad hoc sales.

Key Details

  • Transaction date: March 16, 2026; Form 4 filed March 18, 2026 (appears timely).
  • Options exercised: 8,825; 11,175; and 20,000 shares (total 40,000) at $10.18 each (total ≈ $407,120).
  • Shares sold: 60,000 shares in multiple blocks at ~$57.98–$60.00 per share; gross proceeds ≈ $3,519,201.
  • Shares owned after transaction: Not specified in the provided data.
  • Footnotes of note: F1 indicates sales were pursuant to a Rule 10b5-1 plan. Other footnotes show various option vesting and performance-vesting terms (options were vested/exercisable or had recently vested tranches).

Context

  • This sequence is a common pattern: options were exercised and a large block of shares was sold shortly thereafter — effectively a sale of shares obtained via option exercise (often called a cashless or simultaneous sale).
  • Sales under a 10b5-1 plan are pre‑scheduled and typically viewed as routine dispositions, not necessarily a change in insider sentiment.
  • The filing is factual reporting of the insider’s transactions; it does not by itself indicate the company outlook or insider intent.

Insider Transaction Report

Form 4
Period: 2026-03-16
Burth Jonathan
Chief Operating Officer
Transactions
  • Sale

    Common Stock

    [F1]
    2026-03-16$57.98/sh20,000$1,159,60057,910 total
  • Exercise/Conversion

    Common Stock

    2026-03-16$10.18/sh+8,825$89,82166,735 total
  • Sale

    Common Stock

    [F1]
    2026-03-16$57.98/sh8,825$511,67457,910 total
  • Exercise/Conversion

    Common Stock

    2026-03-16$10.18/sh+11,175$113,73969,085 total
  • Sale

    Common Stock

    [F1]
    2026-03-16$57.98/sh11,175$647,92757,910 total
  • Exercise/Conversion

    Common Stock

    2026-03-16$10.18/sh+20,000$203,56077,910 total
  • Sale

    Common Stock

    [F1]
    2026-03-16$60.00/sh20,000$1,200,00057,910 total
  • Exercise/Conversion

    Non-Qualified Stock Option (Right to Buy)

    [F2]
    2026-03-168,8250 total
    Exercise: $10.18Exp: 2029-12-16Common Stock (8,825 underlying)
  • Exercise/Conversion

    Non-Qualified Stock Option (Right to Buy)

    [F2]
    2026-03-1611,175153,575 total
    Exercise: $10.18Exp: 2030-02-10Common Stock (11,175 underlying)
  • Exercise/Conversion

    Non-Qualified Stock Option (Right to Buy)

    [F2]
    2026-03-1620,000133,575 total
    Exercise: $10.18Exp: 2030-02-10Common Stock (20,000 underlying)
Holdings
  • Non-Qualified Stock Option (Right to Buy)

    [F3]
    Exercise: $10.18Exp: 2030-02-10Common Stock (40,950 underlying)
    40,950
  • Non-Qualified Stock Option (Right to Buy)

    [F2]
    Exercise: $10.18Exp: 2031-01-11Common Stock (34,125 underlying)
    34,125
  • Non-Qualified Stock Option (Right to Buy)

    [F4]
    Exercise: $15.00Exp: 2031-10-21Common Stock (58,043 underlying)
    58,043
  • Non-Qualified Stock Option (Right to Buy)

    [F5]
    Exercise: $15.36Exp: 2032-08-15Common Stock (42,980 underlying)
    42,980
  • Non-Qualified Stock Option (Right to Buy)

    [F6]
    Exercise: $16.91Exp: 2033-03-10Common Stock (14,025 underlying)
    14,025
  • Non-Qualified Stock Option (Right to Buy)

    [F7]
    Exercise: $16.91Exp: 2033-03-10Common Stock (14,205 underlying)
    14,205
  • Non-Qualified Stock Option (Right to Buy)

    [F8]
    Exercise: $26.18Exp: 2034-03-04Common Stock (8,746 underlying)
    8,746
  • Non-Qualified Stock Option (Right to Buy)

    [F9]
    Exercise: $33.36Exp: 2035-03-04Common Stock (13,218 underlying)
    13,218
Footnotes (9)
  • [F1]The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
  • [F2]The stock option is fully vested and currently exercisable.
  • [F3]The stock option is eligible to vest in four tranches if certain performance conditions for each tranche of the option are met by the target date for the applicable performance condition(s) and expire relative to each tranche if the performance conditions for such tranche are not met by the final target date. The performance conditions were partially met and as a result, the first tranche of the option were timely satisfied, resulting in vesting of the option as to 18,200 shares on February 6, 2024. The performance conditions applicable to the fourth tranche of the option were timely satisfied, resulting in vesting of the option as to 22,750 shares on February 20, 2026.
  • [F4]The stock option vests in four equal annual installments beginning on November 27, 2022.
  • [F5]The stock option vests in three equal annual installments beginning on August 15, 2025.
  • [F6]The stock option is eligible to vest if certain performance conditions are met by the target date for the applicable performance condition(s) and expire if the performance conditions are not met by the final target date. The performance conditions applicable were timely satisfied, resulting in vesting of the option as to 14,025 shares on February 20, 2026.
  • [F7]The stock option vests in four equal annual installments beginning on March 10, 2024.
  • [F8]The stock option vests in four equal annual installments beginning on March 4, 2025.
  • [F9]The Reporting Person was granted stock options that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date.
Signature
/s/ Alison Klein, attorney-in-fact for Jonathan Burth|2026-03-17

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT